相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Nonadjunctive Use of Continuous Glucose Monitoring: The End of Fingersticks?
Roy W. Beck et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Glycemic Targets: Standards of Medical Care in Diabetes-2020
DIABETES CARE (2020)
Increased proportion of time in hybrid closed-loop Auto Mode is associated with improved glycaemic control for adolescent and young patients with adult type 1 diabetes using the MiniMed 670G insulin pump
Sara H. Duffus et al.
DIABETES OBESITY & METABOLISM (2020)
What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) Trial
Barbara Kimbell et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Safety and Efficacy of Initializing the Control-IQ Artificial Pancreas System Based on Total Daily Insulin in Adolescents with Type 1 Diabetes
Melissa J. Schoelwer et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2020)
Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial
Sue A. Brown et al.
DIABETES CARE (2020)
REAL-WORLD IMPROVEMENTS IN HYPOGLYCEMIA IN AN INSULIN-DEPENDENT COHORT WITH DIABETES MELLITUS PRE/POST TANDEM BASAL-IQ TECHNOLOGY REMOTE SOFTWARE UPDATE
Jordan E. Pinsker et al.
ENDOCRINE PRACTICE (2020)
Control-IQ Technology in the Real World: The First 30 Days
Lars Mueller et al.
DIABETES (2020)
Glycemic Outcomes for People with Type 1 and Type 2 Diabetes Using Control-IQ Technology: Real-World Data from Early Adopters
Stephanie Habif et al.
DIABETES (2020)
A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm
Laurel H. Messer et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
Tadej Battelino et al.
DIABETES CARE (2019)
Reducing Hypoglycemia in the Real World: A Retrospective Analysis of Predictive Low-Glucose Suspend Technology in an Ambulatory Insulin-Dependent Cohort
Lars Muller et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes
S. A. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018
Nicole C. Foster et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2019)
Exceptional Usability of Tandem t:slim X2 with Basal-IQ Predictive Low-Glucose Suspend (PLGS)-The PROLOG Study
Jordan E. Pinsker et al.
DIABETES (2018)
Optimizing Hybrid Closed-Loop Therapy in Adolescents and Emerging Adults Using the MiniMed 670G System
Laurel H. Messer et al.
DIABETES CARE (2018)
Advances in Closed-Loop Insulin Delivery Systems in Patients with Type 1 Diabetes
Vikash Dadlani et al.
CURRENT DIABETES REPORTS (2018)
Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial
Gregory P. Forlenza et al.
DIABETES CARE (2018)
Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch
Michael P. Stone et al.
DIABETES TECHNOLOGY & THERAPEUTICS (2018)
Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report
David M. Maahs et al.
DIABETES CARE (2016)
Psychometric and screening properties of the WHO-5 well-being index in adult outpatients with Type 1 or Type 2 diabetes mellitus
T. R. S. Hajos et al.
DIABETIC MEDICINE (2013)
分享论文
